Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Results from all Asian patients in VISION Meeting Abstract


Authors: Yang, J. C. H.; Kato, T.; Ahn, M. J.; Sakai, H.; Morise, M.; Chen, Y. M.; Han, J. Y.; Yang, J.; Zhao, J.; Huang, J. L. C.; Berghoff, K.; Bruns, R.; Vioix, H.; Otto, G. P.; Le, X.; Paik, P. K.
Abstract Title: Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Results from all Asian patients in VISION
Meeting Title: ESMO Asia Congress 2022
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 9
Meeting Dates: 2022 Dec 2-4
Meeting Location: Singapore
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-11-01
Start Page: S1565
Language: English
ACCESSION: WOS:000897943700325
DOI: 10.1016/j.annonc.2022.10.358
PROVIDER: wos
Notes: Meeting Abstract: 321MO -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik